Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findlay, V. J.
Right arrow Articles by Tew, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findlay, V. J.
Right arrow Articles by Tew, K. D.
[Cancer Research 66, 6800-6806, July 1, 2006]
© 2006 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

A Novel Role for Human Sulfiredoxin in the Reversal of Glutathionylation

Victoria J. Findlay1, Danyelle M. Townsend2, Taylor E. Morris1, Jacob P. Fraser1, Lin He1 and Kenneth D. Tew1

Departments of 1 Molecular and Cellular Pharmacology and 2 Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina

Requests for reprints: Kenneth D. Tew, Department of Molecular and Cellular Pharmacology, Medical University of South Carolina, Jonathan Lucas Street, Charleston, SC 29425. Phone: 843-792-2514; Fax: 843-792-9588; E-mail: tewk{at}musc.edu.

Modification of protein cysteine residues by disulfide formation with glutathione (glutathionylation) is a reversible posttranslational modification of critical importance in controlling cell signaling events following oxidative and/or nitrosative stress. Here, we show that human sulfiredoxin, a small redox protein conserved in eukaryotes, can act as a novel regulator of the redox-activated thiol switch in cells by catalyzing deglutathionylation of a number of distinct proteins in response to oxidative and/or nitrosative stress. Actin and protein tyrosine phosphatase 1B were identified in vitro as targets of sulfiredoxin 1 (Srx1)–dependent deglutathionylation and confirmed in vivo by two-dimensional gel electrophoresis analysis. In addition, we show that Srx1-dependent deglutathionylation is functionally relevant through restoration of phosphatase activity. Human sulfiredoxin contains one cysteine residue (Cys99) that is conserved in all family members. Mutation of the cysteine residue inhibits deglutathionylation but did not affect its capacity to bind intracellular proteins. Furthermore, sulfiredoxin is not an acceptor molecule for the GS moiety during the reaction process. Using two-dimensional gel electrophoresis, we identified multiple protein targets in vivo that are deglutathionylated by sulfiredoxin following oxidative and/or nitrosative stress. This novel deglutathionylation function of sulfiredoxin suggests it has a central role in redox control with potential implications in cell signaling. (Cancer Res 2006; 66(13): 6800-6)




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. M. Townsend, Y. Manevich, L. He, Y. Xiong, R. R. Bowers Jr., S. Hutchens, and K. D. Tew
Nitrosative Stress-Induced S-Glutathionylation of Protein Disulfide Isomerase Leads to Activation of the Unfolded Protein Response
Cancer Res., October 1, 2009; 69(19): 7626 - 7634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Park, J. J. Mieyal, S. G. Rhee, and P. B. Chock
Deglutathionylation of 2-Cys Peroxiredoxin Is Specifically Catalyzed by Sulfiredoxin
J. Biol. Chem., August 28, 2009; 284(35): 23364 - 23374.
[Abstract] [Full Text] [PDF]


Home page
Mol PlantHome page
X.-H. Gao, M. Bedhomme, D. Veyel, M. Zaffagnini, and S. D. Lemaire
Methods for Analysis of Protein Glutathionylation and their Application to Photosynthetic Organisms
Mol Plant, March 1, 2009; 2(2): 218 - 235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Xie, S. Kole, P. Precht, M. J. Pazin, and M. Bernier
S-Glutathionylation Impairs Signal Transducer and Activator of Transcription 3 Activation and Signaling
Endocrinology, March 1, 2009; 150(3): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wei, H. Jiang, C. P. Matthews, and N. H. Colburn
Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
PNAS, December 16, 2008; 105(50): 19738 - 19743.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Roussel, G. Bechade, A. Kriznik, A. Van Dorsselaer, S. Sanglier-Cianferani, G. Branlant, and S. Rahuel-Clermont
Evidence for the Formation of a Covalent Thiosulfinate Intermediate with Peroxiredoxin in the Catalytic Mechanism of Sulfiredoxin
J. Biol. Chem., August 15, 2008; 283(33): 22371 - 22382.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. M. Townsend
S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response
Mol. Interv., December 1, 2007; 7(6): 313 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Martinez-Ruiz and S. Lamas
Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: Convergences and divergences
Cardiovasc Res, July 15, 2007; 75(2): 220 - 228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.